lung-cancer

Documents about lung-cancer

• Polycationic dendrimers synergizes with gefitinib to overcome EGFR(Ex19Del)-driven resistance in non-small-cell lung cancer.#239784NCBI PubMed Central
• Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)#245515ClinicalTrials.gov
• Development of machine learning and nomogram models to predict lung metastasis and prognosticate survival in breast cancer.#258173NCBI PubMed Central
• Single-cell identifies and validates human circulating Treg subtype/state Treg(fci) in non-small cell lung cancer.#258190NCBI PubMed Central
• CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC#283030ClinicalTrials.gov
• Risk Stratification for the Prediction of Skeletal-Related Events in Patients With Bone Metastases From Non-small Cell Lung Cancer#292609OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Artificial intelligence-assisted risk prediction of postoperative pulmonary complications in non-small cell lung cancer surgery.#297279NCBI PubMed Central
• Dynamic consent framework for low-dose CT scan lung cancer screening: autonomy, privacy, ethical data management.#312493NCBI PubMed Central
• PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC#329511ClinicalTrials.gov
• Identification of selective N-pyridinsulfonyl indole based thiosemicarbazone derivatives as potential antiproliferative agents against lung cancer cells.#338484NCBI PubMed Central
• p53 Orchestrates the Immunogenic-Tolerogenic Pyroptosis Switch in Non-Small Cell Lung Cancer: A Systems Biology Approach.#392842NCBI PubMed Central
• Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC#411392ClinicalTrials.gov
• Mapping the immune landscape in small cell lung cancer unveils a distinct tumor-reactive CD8+ T cell molecular signature#419947bioRxiv / medRxiv
• Improving Decision-Making Encounters in Lung Cancer Treatment: Feasibility and Acceptability of a Low-Literacy Conversation Tool (iDECIDE).#427618NCBI PubMed Central
• Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC#429770ClinicalTrials.gov
• Multitask learning for early treatment response and survival prediction in lung cancer radiotherapy using sequential CBCT imaging.#430798NCBI PubMed Central
• Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial#262149HAL (France)
• Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy#136304ClinicalTrials.gov
• Microwave hyperthermia enhances radiosensitivity of highly invasive non-small cell lung cancer cells via inhibiting Sonic Hedgehog signaling pathway#307764Figshare
• Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)#238110ClinicalTrials.gov
• A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy#424196ClinicalTrials.gov
• Chidamide impedes the progression of non-small cell lung cancer by inhibiting the METTL3/EPHA7 pathway#314659Figshare
• Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.#15042NCBI PubMed Central
• Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)#18627ClinicalTrials.gov
• Bibliometric analysis of research trends and collaboration patterns in cardio-oncology focusing on lung cancer and heart failure.#125564NCBI PubMed Central
• Spatial multi-omics unveils the monoclonal origin, neuroendocrine plasticity, and microenvironment niches in combined small-cell lung cancer.#148364NCBI PubMed Central
• Single-cell spatial transcriptomics reveals tumor microenvironment heterogeneity in primary and lymph node-metastatic small cell lung cancer.#148375NCBI PubMed Central
• High prevalence of frailty identified with G8, compared with clinical frailty scale, in older patients with suspected lung cancer.#209491NCBI PubMed Central
• Tobacco use and eligibility for lung cancer screening among dental patients at an academic institution in Houston, Texas.#214226NCBI PubMed Central
• The evolving disease burden of lung cancer (2014-2023) in Qingdao, China: An observational trend study with projections.#227997NCBI PubMed Central
• Observational study of predictors and outcomes of lung cancer in never-smokers in the UK (OLIVE): study protocol.#280879NCBI PubMed Central
• Impact of Immune Checkpoint Inhibitor-Combined Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer With Brain Metastases#311895HAL (France)
• [Mechanisms of Macrophage Efferocytosis-driven Remodeling of Lung Cancer 
Microenvironment Structure and Angiogenesis and Prospects for Clinical Intervention].#322967NCBI PubMed Central
• Lung cancer risk prediction models and asbestos exposure: a validation study on the Western Australia Asbestos Review Program.#323160NCBI PubMed Central
• Publication Characteristics and Reporting Quality of GBD-Derived Burden of Disease Studies: A Cross-Sectional Analysis of Lung Cancer.#334894NCBI PubMed Central
• Vaccines Containing Mouse and Human Endogenous Retroviruses Demonstrate Opposite Effects on Lung Metastasis in a Murine Mammary Cancer Model#355671Scholars Crossing
• Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy#363612ClinicalTrials.gov
• Development and validation of an explainable machine learning model for mortality prediction in ICU patients with lung cancer.#368026NCBI PubMed Central
• Best practices for respiratory function training in perioperative patients with lung cancer: A scoping review and evidence synthesis.#382583NCBI PubMed Central
• PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients#390911ClinicalTrials.gov
• Acute and lifelong exercise modulate the tumorigenic potential of human lung cancer cells and their susceptibility to cisplatin.#404509NCBI PubMed Central
• Study of BO-112 With Radiotherapy and Nivolumab for Metastatic Refractory NSCLC#411387ClinicalTrials.gov
• Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI#429689ClinicalTrials.gov
• Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer.#436974NCBI PubMed Central
• Synergistic Anti‐Lung Cancer Effects of Cytarabine and a NCBI ‐Registered Streptococcus via Modulation of Apoptotic and Survival Pathways#442507HAL (France)
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma#184850ClinicalTrials.gov
• Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO#141014ClinicalTrials.gov
• PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After Anti- PD- 1/L1 Therapy#184828ClinicalTrials.gov
• Translating Liquid Biopsy into Practice- The Promise and Challenges of Circulating Tumor Cells in Ovarian and Lung Cancer Management.#4398NCBI PubMed Central
• Telehealth-Supported Physical Activity Among Veterans With a History of Lung Cancer: Protocol for a Single-Arm Feasibility Study.#14783NCBI PubMed Central